A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

NCT05755035 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Immunodeficiency Diseases (PID)

Interventions

BIOLOGICAL: TAK-881
BIOLOGICAL: HYQVIA

Sponsor

Takeda

Collaborators

[object Object]